Yuhan Corp operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Yuhan Corp with three other
pharmaceutical manufacturers in Asia:
Green Cross Holdings Corporation
sales of 1.35 trillion Korean Won [US$1.20 billion]
China Resources Double-Crane Pharmaceutical Company Limited
(5.49 billion Chinese Renmimbi [US$828.81 million]
of which 62%
was Non- transfusion), and
Hisamitsu Pharmaceutical Co Inc
based in Japan
(161.85 billion Japanese Yen [US$1.43 billion]
of which 100%
Yuhan Corp reported sales of 1.32 trillion Korean Won (US$1.17 billion)
December of 2016.
increase of 17.0%
versus 2015, when the company's sales were 1.13 trillion Korean Won.
Sales at Yuhan Corp have increased during each of the previous five years
(and since 2011, sales have increased a total of 94%).